Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Small Cell Lung Carcinoma 4 Nasopharyngeal Carcinoma 3 Triple Negative Breast Neoplasms 2 Sarcoma 2 Neoplasm Metastasis 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Solid Tumors 1 Recurrence 1 Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma, Adenoid Cystic 1

Interventions

Specimen Handling 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Epirubicin 2 pembrolizumab 1 lenvatinib 1 enfortumab vedotin 1 anlotinib 1 amivantamab 1 Pemetrexed 1 Observation 1 Ipilimumab 1 Imatinib Mesylate 1 Glutamate Carboxypeptidase II 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Blood Specimen Collection 1 BMS-906024 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Adenoid Cystic × anlotinib × 90 days × Clear all

NCT07616141 2026-06-01

NAET4-SNACC

Eye & ENT Hospital of Fudan University

Phase 2 Not yet recruiting

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡